HK1126431A1 - Powder compositions for inhalation - Google Patents
Powder compositions for inhalationInfo
- Publication number
- HK1126431A1 HK1126431A1 HK09105425.5A HK09105425A HK1126431A1 HK 1126431 A1 HK1126431 A1 HK 1126431A1 HK 09105425 A HK09105425 A HK 09105425A HK 1126431 A1 HK1126431 A1 HK 1126431A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhalation
- powder compositions
- compositions
- powder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0525254.9A GB0525254D0 (en) | 2005-12-12 | 2005-12-12 | Powder compositions for inhalation |
| PCT/EP2006/011941 WO2007068443A1 (en) | 2005-12-12 | 2006-12-12 | Powder compositions for inhalation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1126431A1 true HK1126431A1 (en) | 2009-09-04 |
Family
ID=35735955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09105425.5A HK1126431A1 (en) | 2005-12-12 | 2009-06-17 | Powder compositions for inhalation |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20100015238A1 (de) |
| EP (1) | EP1962797B2 (de) |
| JP (1) | JP5207976B2 (de) |
| CN (1) | CN101325945B (de) |
| AU (1) | AU2006326315B2 (de) |
| CA (1) | CA2632831C (de) |
| EA (1) | EA021901B1 (de) |
| ES (1) | ES2832801T3 (de) |
| GB (1) | GB0525254D0 (de) |
| HK (1) | HK1126431A1 (de) |
| IL (1) | IL191809A (de) |
| NO (1) | NO346661B1 (de) |
| NZ (1) | NZ569012A (de) |
| WO (1) | WO2007068443A1 (de) |
| ZA (1) | ZA200804654B (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070212422A1 (en) * | 1999-11-10 | 2007-09-13 | Manfred Keller | Dry powder for inhalation |
| GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| GB0326632D0 (en) | 2003-11-14 | 2003-12-17 | Jagotec Ag | Dry powder formulations |
| GB0602897D0 (en) * | 2006-02-13 | 2006-03-22 | Jagotec Ag | Improvements In Or Relating To Dry Powder Inhaler Devices |
| GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| GB0622818D0 (en) * | 2006-11-15 | 2006-12-27 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0625303D0 (en) * | 2006-12-19 | 2007-01-24 | Jagotec Ag | Improvements in and relating to metered dose inhalers |
| EP2060268A1 (de) * | 2007-11-15 | 2009-05-20 | Novo Nordisk A/S | Pharmazeutische Zusammensetzungen für die Zufuhr von Peptiden über die Lunge oder Nase |
| WO2010003465A2 (en) * | 2008-07-11 | 2010-01-14 | Universita' Degli Studi Di Parma | A drug powder for inhalation administration and a process thereof |
| PT2417106T (pt) * | 2009-04-09 | 2017-02-13 | Novartis Ag | Processo para preparação de sais de pirrolidínio |
| AU2009100698B4 (en) * | 2009-07-17 | 2010-04-15 | Astrazeneca Ab | Combination |
| GB0918249D0 (en) | 2009-10-19 | 2009-12-02 | Respivert Ltd | Compounds |
| US20130177651A1 (en) | 2010-09-03 | 2013-07-11 | Pharmaterials Limited | Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler |
| UY33337A (es) | 2010-10-18 | 2011-10-31 | Respivert Ltd | DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS |
| GB201110058D0 (en) * | 2011-06-15 | 2011-07-27 | 3M Innovative Properties Co | Medicinal inhalation devices, valves and components thereof |
| US20140294969A1 (en) * | 2011-08-01 | 2014-10-02 | Monash University | Method and formulation for inhalation |
| WO2013091006A1 (en) * | 2011-12-23 | 2013-06-27 | Monash University | Process for dry powder blending |
| EP2800780B1 (de) * | 2012-01-03 | 2018-03-14 | Phase Change Energy Solutions, Inc. | Zusammensetzungen mit phasenwechselmaterialien und herstellungsverfahren dafür |
| SG11201404522VA (en) | 2012-03-13 | 2014-10-30 | Respivert Ltd | Crystalline pi3 kinase inhibitors |
| CN102614154A (zh) * | 2012-03-31 | 2012-08-01 | 中山大学 | 细辛脑干粉吸入剂及其制备方法 |
| KR20140147891A (ko) | 2012-04-13 | 2014-12-30 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 응집체 입자 |
| JP5087182B1 (ja) * | 2012-06-13 | 2012-11-28 | クリニプロ株式会社 | 吸入用パウダーの製造方法 |
| CN102793689A (zh) * | 2012-09-12 | 2012-11-28 | 郑州大学 | 一种抗肿瘤药物2-甲氧基雌二醇干粉吸入剂及其制备方法 |
| CN103417507B (zh) * | 2013-08-23 | 2015-12-02 | 王显著 | 布地奈德药物组合物 |
| HUE049339T2 (hu) | 2014-09-09 | 2020-09-28 | Vectura Ltd | Glikopirrolátot tartalmazó készítmény, eljárás és berendezés |
| WO2016067252A1 (en) | 2014-10-31 | 2016-05-06 | Glaxosmithkline Intellectual Property Development Limited | Powder formulation |
| BR112017009315A2 (pt) * | 2014-11-05 | 2017-12-19 | Glenmark Pharmaceuticals Ltd | composição de pó seco farmacêutico inalável, processo para preparar uma composição de pó seco farmacêutico inalável, e, método para tratar transtornos respiratórios. |
| RU2587331C1 (ru) * | 2015-06-19 | 2016-06-20 | Общество с ограниченной ответственностью "Полигепазол" | Способ получения фармацевтической композиции адеметионина и его лекарственной формы |
| GB201515310D0 (en) * | 2015-08-27 | 2015-10-14 | Jagotec Ag | Pharmaceutical composition |
| EP3175842B1 (de) | 2015-12-03 | 2019-12-11 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Trockenpulvermischverfahren |
| KR102637303B1 (ko) * | 2017-05-11 | 2024-02-20 | 키에시 파르마슈티시 엣스. 피. 에이. | 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제의 제조 방법 |
| CA3059824A1 (en) * | 2017-05-11 | 2018-11-15 | Chiesi Farmaceutici S.P.A. | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic |
| CN109200034A (zh) * | 2017-06-30 | 2019-01-15 | 正大天晴药业集团股份有限公司 | 一种可吸入干粉形式的组合物及其制备方法 |
| CN108785273B (zh) * | 2018-09-18 | 2021-01-01 | 四川海思科制药有限公司 | 一种恩替卡韦胶囊药物组合物及其制备方法 |
| EP3673895A1 (de) * | 2018-12-28 | 2020-07-01 | Université Libre de Bruxelles | Trockenpulverinhalationsformulierung und deren verwendung zur therapeutische behandlung von lungen |
| CN109745564A (zh) * | 2019-01-28 | 2019-05-14 | 上海方予健康医药科技有限公司 | 一种吸入干粉组合物的制备方法 |
| WO2021022213A1 (en) * | 2019-07-31 | 2021-02-04 | Riordan Clinic | Intravenous vitamin c therapy protocol for the treatment of cancer |
| CN110638795A (zh) * | 2019-11-07 | 2020-01-03 | 慧生医学科技(徐州)有限公司 | 一种可吸入药物及其制备方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD98022A1 (de) | 1972-06-30 | 1973-06-12 | ||
| US4672108A (en) | 1981-12-07 | 1987-06-09 | Hoffmann-La Roche Inc. | Crystalline human leukocyte interferon |
| IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
| GB8622090D0 (en) | 1986-09-12 | 1986-10-22 | Wellcome Found | Pharmacologically active compounds |
| US5874063A (en) | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
| US5830853A (en) * | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| ATE193455T1 (de) | 1995-12-07 | 2000-06-15 | Jago Pharma Ag | Inhalator zur mehrfachen dosisweisen abgabe eines pharmakologischen trockenpulvers |
| GB9806462D0 (en) | 1998-03-26 | 1998-05-27 | Glaxo Group Ltd | Improved compositions for inhalation |
| CA2347856C (en) | 1998-11-13 | 2009-02-17 | Jago Research Ag | Dry powder for inhalation |
| US20070212422A1 (en) | 1999-11-10 | 2007-09-13 | Manfred Keller | Dry powder for inhalation |
| GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| SI1158958T1 (sl) | 1999-03-05 | 2007-10-31 | Chiesi Farma Spa | Izboljĺ ani praĺ kasti farmacevtski sestavki za inhalacijo |
| EP1129705A1 (de) | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Pulverformulierung zur Inhalation |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| WO2002007705A1 (en) | 2000-07-20 | 2002-01-31 | Campina B.V. | Carrier material for dry powder inhalation |
| JP4125512B2 (ja) | 2000-11-29 | 2008-07-30 | 伊藤ハム株式会社 | 粉末製剤及びその製造方法 |
| AU2002222118A1 (en) | 2000-11-30 | 2002-06-11 | Vectura Limited | Pharmaceutical compositions for inhalation |
| ATE446085T1 (de) † | 2000-11-30 | 2009-11-15 | Vectura Ltd | Partikel zur verwendung in einer pharmazeutischen zusammensetzung |
| US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
| CA2522158C (en) * | 2003-04-14 | 2018-03-20 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
| BRPI0414428A (pt) | 2003-09-15 | 2006-11-14 | Vectura Ltd | composições farmacêuticas |
| GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| GB0326632D0 (en) | 2003-11-14 | 2003-12-17 | Jagotec Ag | Dry powder formulations |
| GB0409703D0 (en) * | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
| GB0622818D0 (en) | 2006-11-15 | 2006-12-27 | Jagotec Ag | Improvements in or relating to organic compounds |
-
2005
- 2005-12-12 GB GBGB0525254.9A patent/GB0525254D0/en not_active Ceased
-
2006
- 2006-12-12 NO NO20082488A patent/NO346661B1/no unknown
- 2006-12-12 CA CA2632831A patent/CA2632831C/en active Active
- 2006-12-12 NZ NZ569012A patent/NZ569012A/xx unknown
- 2006-12-12 EA EA200870002A patent/EA021901B1/ru not_active IP Right Cessation
- 2006-12-12 CN CN200680046598.1A patent/CN101325945B/zh active Active
- 2006-12-12 ES ES06829526T patent/ES2832801T3/es active Active
- 2006-12-12 EP EP06829526.0A patent/EP1962797B2/de active Active
- 2006-12-12 JP JP2008544856A patent/JP5207976B2/ja active Active
- 2006-12-12 US US12/086,345 patent/US20100015238A1/en not_active Abandoned
- 2006-12-12 AU AU2006326315A patent/AU2006326315B2/en active Active
- 2006-12-12 WO PCT/EP2006/011941 patent/WO2007068443A1/en active Application Filing
-
2008
- 2008-05-28 ZA ZA2008/04654A patent/ZA200804654B/en unknown
- 2008-05-29 IL IL191809A patent/IL191809A/en active IP Right Grant
-
2009
- 2009-06-17 HK HK09105425.5A patent/HK1126431A1/xx unknown
-
2012
- 2012-09-05 US US13/604,280 patent/US8877251B2/en active Active
-
2014
- 2014-09-22 US US14/492,390 patent/US20150037425A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007068443A1 (en) | 2007-06-21 |
| US20100015238A1 (en) | 2010-01-21 |
| US20150037425A1 (en) | 2015-02-05 |
| CA2632831A1 (en) | 2007-06-21 |
| EP1962797B1 (de) | 2020-10-28 |
| ES2832801T3 (es) | 2021-06-11 |
| GB0525254D0 (en) | 2006-01-18 |
| CA2632831C (en) | 2016-07-12 |
| EP1962797B2 (de) | 2024-05-29 |
| ZA200804654B (en) | 2014-07-30 |
| CN101325945B (zh) | 2014-11-26 |
| US20120328704A1 (en) | 2012-12-27 |
| NO20082488L (no) | 2008-05-29 |
| NZ569012A (en) | 2012-08-31 |
| EP1962797A1 (de) | 2008-09-03 |
| EA021901B1 (ru) | 2015-09-30 |
| CN101325945A (zh) | 2008-12-17 |
| IL191809A0 (en) | 2008-12-29 |
| JP5207976B2 (ja) | 2013-06-12 |
| NO346661B1 (no) | 2022-11-21 |
| NO20082488A (no) | 2008-05-29 |
| IL191809A (en) | 2014-04-30 |
| EA200870002A1 (ru) | 2009-12-30 |
| AU2006326315A1 (en) | 2007-06-21 |
| AU2006326315B2 (en) | 2013-07-11 |
| JP2009518449A (ja) | 2009-05-07 |
| US8877251B2 (en) | 2014-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL191809A0 (en) | Powder compositions for inhalation | |
| EP1906776A4 (de) | Tabakzusammensetzungen | |
| PL1858635T3 (pl) | Proszek mikrokapsułkowy | |
| IL195781A0 (en) | Powder inhaler | |
| ZA201305658B (en) | Antiperspirant compositions | |
| AP2008004547A0 (en) | Petsticidal compositions | |
| GB0503337D0 (en) | Compositions | |
| IL186721A0 (en) | Bioenhanced compositions | |
| GB0526283D0 (en) | Compositions | |
| ZA200801174B (en) | Antiperspirant compositions | |
| ZA200806185B (en) | Antiperspirant compositions | |
| IL186093A0 (en) | Lignan-containing compositions | |
| GB0501365D0 (en) | Compositions | |
| IL190321A0 (en) | Compositions containing saratin | |
| GB0524128D0 (en) | Compositions | |
| ZA200804723B (en) | Metallurgical powder composition | |
| PL1971320T3 (pl) | Kompozycje antyperspiranta | |
| ZA200802756B (en) | Aerosolformulation for inhalation | |
| GB0526282D0 (en) | Compositions | |
| GB0501364D0 (en) | Compositions | |
| GB0525842D0 (en) | Improved compositions for inhalation | |
| GB0506065D0 (en) | Compositions | |
| HU0500453D0 (en) | Powder inhaler | |
| PL372180A1 (pl) | Zasypka do stóp | |
| GB0504438D0 (en) | Antiperspirant compositions |